Evidence map›Paper›PMID 25285446›Full record

ArticlePloS one2014

Expression cloning of camelid nanobodies specific for Xenopus embryonic antigens.

Keiji Itoh, Sergei Y Sokol

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Keiji ItohDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Sergei Y SokolDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Icahn School of Medicine at Mount Sinai · US

Funding

Patterning of the Vertebrate Nervous SystemR01NS040972 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SOKOL, SERGEI · 2001 to 2015
$4.8M
Camelid antibodies as sensitive proteomics tools for developmental studiesR21HD080622 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SOKOL, SERGEI · 2014 to 2015
$461k
Patterning of the Vertebrate Nervous SystemR56NS040972 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SOKOL, SERGEI · 2011 to 2011
$424k
NICHD NIH HHS HD80622NICHD NIH HHS R21 HD080622NINDS NIH HHS NS40972NINDS NIH HHS R01 NS040972NINDS NIH HHS R56 NS040972
6 · The paper itself

Abstract

Developmental biology relies heavily on the use of conventional antibodies, but their production and maintenance involves significant effort. Here we use an expression cloning approach to identify variable regions of llama single domain antibodies (known as nanobodies), which recognize specific embryonic antigens. A nanobody cDNA library was prepared from lymphocytes of a llama immunized with Xenopus embryo lysates. Pools of bacterially expressed cDNAs were sib-selected for the ability to produce specific staining patterns in gastrula embryos. Three different nanobodies were isolated: NbP1 and NbP3 stained yolk granules, while the reactivity of NbP7 was predominantly restricted to the cytoplasm and the cortex. The isolated nanobodies recognized specific protein bands in immunoblot analysis. A reverse proteomic approach identified NbP1 target antigen as EP45/Seryp, a serine protease inhibitor. Given the unique stability of nanobodies and the ease of their expression in diverse systems, we propose that nanobody cDNA libraries represent a promising resource for molecular markers for developmental biology.

Indexed as

CamelusAmino Acid SequenceAnimalsAntibodies, MonoclonalAntibody SpecificityAntigensCloning, MolecularEmbryo, NonmammalianFemaleGastrulaHEK293 CellsHumansImmunoprecipitationMolecular Sequence DataSingle-Domain AntibodiesXenopusAntibodies, MonoclonalAntigensSingle-Domain AntibodiesXenopus Proteins

Identifiers

PMID25285446
PMCPMC4186775
OpenAlexW1968631841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.